Statement Of Cash Flows [Abstract]

Biotage - Filing #689619

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations before changes in working capital
380,000,000 SEK
332,000,000 SEK
Increase (decrease) in working capital
3 9 SEK
21,000,000 SEK
Adjustments for decrease (increase) in trade and other receivables
45,000,000 SEK
16,000,000 SEK
Adjustments for increase (decrease) in trade and other payables
51,000,000 SEK
60,000,000 SEK
Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss
102,000,000 SEK
75,000,000 SEK
Income taxes paid, classified as operating activities
52,000,000 SEK
16,000,000 SEK
Cash flows from (used in) financing activities [abstract]
Dividends paid to equity holders of parent, classified as financing activities
102,000,000 SEK
98,000,000 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.